Related Experiment Video
Updated: Sep 9, 2025

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
Consistency in treatment effects and statistical significance between early-stage pregnancy endpoints and live birth
Qian Feng1, Wanlin Li1, James Crispin1
1Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
Importance:
Live births are the "gold standard" for assessing infertility treatments but are less frequently reported than clinical pregnancy. Identifying approaches to interpret randomized controlled trials (RCTs) without live birth data is essential.
Objective:
To evaluate the correlation between treatment effects and the consistency of statistical significance in conclusions drawn from live birth versus early-stage pregnancy endpoints (an umbrella term defined as biochemical, clinical, or ongoing pregnancy) in RCTs reporting both outcomes.
Data Sources:
We systematically searched EMBASE, MEDLINE, and CENTRAL for RCTs in infertility from January 1, 2012 to August 30, 2023.
Study Selection And Synthesis:
Randomized controlled trials involving subfertile women reporting contingency tables for live birth and at least one early-stage pregnancy endpoint were eligible. Contingency tables on pregnancy or live births were manually extracted from the trial publications. We calculated Spearman's rho for treatment effects between early-stage pregnancy endpoints and live birth and compared their statistical significance using Chi-square tests. The above analyses were then conducted in prespecified subgroups.
Main Outcomes:
The correlation between treatment effects and the consistency of statistical significance in conclusions drawn from live birth versus early-stage pregnancy endpoints.
Results:
Among 8,757 records, 1,281 infertility RCTs were eligible. The Spearman's rho for treatment effects was 0.78 (95% confidence interval [CI]: 0.69-0.86, P<.001; 169 RCTs) between biochemical pregnancy and live birth, 0.87 (95% CI: 0.83-0.90, P<.01; 429 RCTs) between clinical pregnancy and live birth, and 0.96 (95% CI: 0.92-0.98, P<.01; 138 RCTs) between ongoing pregnancy and live birth. Statistical significance between early-stage pregnancy endpoints and live birth was consistent in above 88% of trials. The correlation of treatment effects between clinical or ongoing pregnancy and live birth remained robust in subgroups of infertility treatments, including ovarian stimulation for medically assisted reproduction treatment.
Conclusion And Relevance:
A strong correlation was observed between clinical or ongoing pregnancy and live birth, supporting the rationale for using clinical or ongoing pregnancy data to assess treatment effectiveness when live birth data are limited or unavailable. However, the risk of intervention-related pregnancy loss must be considered during the assessment.
Related Concept Videos
Regression Toward the Mean
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Statistical Significance
Testing a Claim about Mean: Known Population SD
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...

